GTHP (Guided Therapeutics) Cyclically Adjusted PB Ratio: (As of Jul. 15, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

GTHP Guided Therapeutics Inc GTHP
18 GF Score
Price $0.28
! 4 Warning Signs
View Full Analysis

What is Guided Therapeutics Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Guided Therapeutics  (OTCPK:GTHP) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Guided Therapeutics Cyclically Adjusted PB Ratio Related Terms


Guided Therapeutics Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Guided Therapeutics's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guided Therapeutics Cyclically Adjusted PB Ratio Chart

Guided Therapeutics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Guided Therapeutics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

GTHP vs CTSO, IRIX, ICCM: Cyclically Adjusted PB Ratio Comparison

For the Medical Devices subindustry, Guided Therapeutics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Guided Therapeutics Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Guided Therapeutics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Guided Therapeutics's Cyclically Adjusted PB Ratio falls into.


GTHP
18GF Score
Guided Therapeutics Inc GTHP
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Guided Therapeutics Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Guided Therapeutics's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 is calculated as:

For example, Guided Therapeutics's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book=Book Value per Share/CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.061/330.2130*330.2130
=-0.061

Current CPI (Mar. 2026) = 330.2130.

Guided Therapeutics Quarterly Data

Book Value per Share CPI Adj_Book
201606 0.000 241.018 0.000
201609 0.000 241.428 0.000
201612 -10,568.000 241.432 -14,454.136
201703 -5,133.500 243.801 -6,953.000
201706 -3,836.333 244.955 -5,171.591
201709 -1,123.083 246.819 -1,502.545
201712 -329.968 246.524 -441.984
201803 -109.191 249.554 -144.483
201806 -44.893 251.989 -58.829
201809 -31.200 252.439 -40.812
201812 -6.231 251.233 -8.190
201903 -5.066 254.202 -6.581
201906 -5.842 256.143 -7.531
201909 -5.672 256.759 -7.295
201912 -5.345 256.974 -6.868
202003 -1.056 258.115 -1.351
202006 -1.438 257.797 -1.842
202009 -1.255 260.280 -1.592
202012 -1.033 260.474 -1.310
202103 -0.893 264.877 -1.113
202106 -0.918 271.696 -1.116
202109 -0.879 274.310 -1.058
202112 -0.901 278.802 -1.067
202203 -0.813 287.504 -0.934
202206 -0.399 296.311 -0.445
202209 -0.134 296.808 -0.149
202212 -0.123 296.797 -0.137
202303 -0.116 301.836 -0.127
202306 -0.124 305.109 -0.134
202309 -0.128 307.789 -0.137
202312 -0.126 306.746 -0.136
202403 -0.126 312.332 -0.133
202406 -0.137 314.175 -0.144
202409 -0.131 315.301 -0.137
202412 -0.121 315.605 -0.127
202503 -0.093 319.799 -0.096
202506 -0.097 322.561 -0.099
202509 -0.087 324.800 -0.088
202512 -0.088 324.054 -0.090
202603 -0.061 330.213 -0.061

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Guided Therapeutics Business Description

Address 5835 Peachtree Corners East, Suite B, Peachtree Corners, GA, USA, 30092
Guided Therapeutics Inc is a medical technology company. It is engaged in developing medical devices that have the potential to improve healthcare. Its primary focus is the sales and marketing of its LuViva Advanced Cervical Scan non-invasive cervical cancer detection device and the extension of its cancer detection technology into other cancers, including esophageal. The company generates revenue from the sale of medical devices.
18GF Score

Get the complete analysis for GTHP

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.28
Price